{"gene":"HOXA1","run_date":"2026-04-28T18:06:53","timeline":{"discoveries":[{"year":1991,"finding":"Targeted disruption of Hox-1.6 (Hoxa1) in mice causes defects in rhombomeres 4-7, including absence of cranial nerves and ganglia, and malformed inner ears and skull bones, demonstrating Hoxa1 is required for regional specification along the rostrocaudal axis in its most rostral domain of expression.","method":"Homologous recombination gene targeting in embryonic stem cells, mouse knockout","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1-2 — independently replicated in two separate knockout studies (PMID:1680563 and PMID:1346922) with defined phenotypic readouts","pmids":["1680563","1346922"],"is_preprint":false},{"year":1992,"finding":"A retinoic acid-responsive enhancer located 3' of the Hoxa1 gene (containing a RARE identical to that of RARbeta) is required for retinoic acid-induced transcriptional activation of Hoxa1; the RARE alone is insufficient and other sequences within the enhancer also contribute.","method":"DNase I hypersensitivity mapping, lacZ minigene reporter assays in transgenic mice, F9 teratocarcinoma cell transfection","journal":"Mechanisms of development","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods including in vivo reporter assays and point-mutation analysis of the RARE in a single study","pmids":["1360810"],"is_preprint":false},{"year":1995,"finding":"An evolutionarily conserved enhancer within the Hoxa1 locus containing a retinoic acid response element drives expression in neuroepithelium caudal to rhombomere 4; point mutations in the RARE abolish this expression, supporting a direct role for endogenous retinoids in Hoxa1 regulation and hindbrain patterning.","method":"Transgenic mouse reporter assays with RARE point mutations","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 1-2 — in vivo reporter assay with mutagenesis","pmids":["7743939"],"is_preprint":false},{"year":1998,"finding":"HOXA1 and HOXB1, together with cofactor PBX1, bind to Hox-Pbx consensus sites in the EphA2 enhancer and transcriptionally activate EphA2 expression; this is required for rhombomere 4-specific EphA2 expression in vivo, as EphA2 expression is reduced in Hoxa1/Hoxb1 double mutants.","method":"In vitro DNA binding (EMSA/co-immunoprecipitation), co-transfection reporter assays, transgenic embryo analysis, double-mutant mice","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro binding confirmed with in vivo genetic validation using double-mutant mice","pmids":["9733765"],"is_preprint":false},{"year":1998,"finding":"Hoxa1 and Hoxb1 genetically synergize to pattern the hindbrain, cranial nerves, and second pharyngeal arch; double null mutants show loss of all second arch-derived elements and complete disruption of ear development, phenotypes not seen in single mutants.","method":"Genetic epistasis via compound double-mutant mice, neurofilament staining, retrograde motor neuron labeling","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 — two independent labs (PMID:9463359 and PMID:9463349) using double-mutant genetic analysis with multiple cellular phenotype readouts","pmids":["9463359","9463349"],"is_preprint":false},{"year":1998,"finding":"Hoxa1 is the primary mediator of the retinoic acid response of the Hoxb1 autoregulatory enhancer (b1-ARE) in vivo; this function requires binding of SOX/OCT heterodimers to the b1-ARE. HOXA1 has significantly lower transcriptional activity than HOXB1 from the b1-ARE, with the differential activity mapped to the HOXB1 N-terminal transcriptional activation domain.","method":"Transgenic mice, cell transfection reporter assays, SOX/OCT site mutagenesis, analysis of Hoxa1 mutant mice","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — mechanistic domain mapping combined with in vivo transgenic and mutant mouse validation","pmids":["11278854"],"is_preprint":false},{"year":1998,"finding":"Hoxa1 is required to set the anterior limit of Hoxb1 expression at the r3/r4 boundary; loss of Hoxa1 initiates a cascade of gene misexpressions causing misspecification of hindbrain compartments r2 through r5, followed by ectopic apoptosis.","method":"Genetic epistasis via single and double knockout mice, molecular marker analysis","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 — double-mutant genetic epistasis with defined molecular cascade","pmids":["10662633"],"is_preprint":false},{"year":1998,"finding":"The YPWM motif of HOXA1 is strictly required for cooperative DNA binding with PBX cofactors in vitro and in vivo; the YPWM motif contacts the PBX homeodomain. The GKFQ domain of PBX increases DNA binding by PBX but is not a primary contact site for HOXA1's YPWM motif.","method":"In vitro DNA binding assays (EMSA), co-transfection, deletion/mutagenesis of E2A-PBX","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstituted binding assays with defined mutagenesis of interaction surfaces","pmids":["9582372"],"is_preprint":false},{"year":1999,"finding":"Hoxa1 and Hoxb1 double mutants show loss of both rhombomeres 4 and 5 and selective loss of the second branchial arch, demonstrating overlapping functions in rhombomere identity specification; the aberrant hindbrain subsequently undergoes size regulation through apoptosis.","method":"Double knockout mice, molecular marker analysis, histology","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 — double-mutant genetic analysis with defined cellular and molecular phenotypes","pmids":["10529420"],"is_preprint":false},{"year":2001,"finding":"Hoxa1 synergizes with Hoxb1 to generate cranial neural crest cells from r4; loss of both genes in the neuroepithelium reduces r4 size and abolishes its ability to generate neural crest cells in a cell-autonomous manner.","method":"Ectoderm-specific double-mutant mice, molecular and lineage analysis, grafting experiments in cultured embryos","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 — cell-autonomous defect established by grafting experiments combined with genetic double-mutant analysis","pmids":["11532923"],"is_preprint":false},{"year":2001,"finding":"Ectopic neuronal groups established by misspecification in Hoxa1 null mice (from the r3-r4 level, including r2-identity progenitors) form a supernumerary functional neuronal circuit that integrates the respiratory rhythm-generating network at birth.","method":"Hoxa1 null mouse analysis, electrophysiology, neuroanatomical tracing","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 — defined cellular phenotype with functional circuit validation, single study","pmids":["11466434"],"is_preprint":false},{"year":2002,"finding":"HOXA1 is functionally interchangeable with HOXB1 when protein-coding sequences are swapped at the respective loci in mice, demonstrating that subfunctionalization of Hox1 paralogs is mediated primarily by divergence of transcriptional regulatory elements rather than protein sequence differences.","method":"Knock-in mouse lines with swapped coding regions, insertion of Hoxb1 autoregulatory enhancer into Hoxa1 locus","journal":"Developmental cell","confidence":"High","confidence_rationale":"Tier 1-2 — protein swap reconstitution in vivo with multiple genetic combinations tested","pmids":["16890163"],"is_preprint":false},{"year":2002,"finding":"Hoxa1 homeodomain residues 2 and 3 (asparagine and alanine, unusual compared to typical basic residues) function as specificity determinants when Hoxa1 acts as a monomer, but do not influence target specificity in Pbx1a-Hoxa1 heterodimers in vitro; however, on the Hoxb1 autoregulatory enhancer these residues can modulate Hoxa1 activity even in the presence of Pbx, in a cell-type-dependent manner.","method":"Site-directed mutagenesis, cell transfection reporter assays, in vitro DNA binding","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 1 — in vitro reconstitution with mutagenesis, single study","pmids":["12060683"],"is_preprint":false},{"year":2002,"finding":"Forced HOXA1 expression in human mammary carcinoma cells upregulates Bcl-2 transcription, promotes cell survival, anchorage-independent growth, and oncogenic transformation of immortalized mammary epithelial cells with in vivo tumor formation.","method":"Forced expression in human mammary cells, soft agar colony formation, in vivo tumor formation, Bcl-2 reporter assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — multiple functional assays in one lab; Bcl-2 as direct downstream target established by transcriptional assay","pmids":["12482855"],"is_preprint":false},{"year":2005,"finding":"E-cadherin-mediated cell-cell contact increases HOXA1 expression in mammary carcinoma cells through Rac1 signaling; HOXA1 is required downstream of E-cadherin for anchorage-independent proliferation and survival.","method":"E-cadherin blocking antibody, EGTA treatment, calcium rescue, Rac1 inhibition, HOXA1 siRNA knockdown","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — multiple pharmacological and genetic perturbations in a single lab study","pmids":["16373333"],"is_preprint":false},{"year":2007,"finding":"HOXA1-mediated oncogenic transformation of mammary epithelial cells requires activation of the p44/42 MAP kinase pathway; HOXA1 transcriptionally upregulates GRB2 and MEK1 and increases ERK phosphorylation, and MEK1 inhibition blocks HOXA1-driven proliferation, survival, and transformation.","method":"Microarray gene expression profiling, forced expression/depletion of HOXA1, MEK1 inhibitor treatment, Western blot","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 — pathway placement by pharmacological epistasis combined with expression profiling, single lab","pmids":["17213808"],"is_preprint":false},{"year":2007,"finding":"Polycomb group protein SUZ12 associates with the Hoxa1 RARE prior to retinoic acid treatment; RA treatment attenuates SUZ12 association and decreases H3K27me3 at the Hoxa1 RARE, while increasing H3ac, H3K4me2, and RNA Pol II occupancy. RAR-gamma and RXR-alpha are present at the RARE before and during RA treatment.","method":"Chromatin immunoprecipitation (ChIP) in F9 embryonal carcinoma cells","journal":"Journal of molecular biology","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP with multiple histone marks and factors, single lab","pmids":["17663992"],"is_preprint":false},{"year":2008,"finding":"Hoxa1 is required for retinoic acid-induced neuronal differentiation of embryonic stem cells; Hoxa1 null ES cells fail to express neuronal markers and instead upregulate endodermal markers (Sox17); re-introduction of Hoxa1 rescues neuronal differentiation. Hoxa1 may promote neural differentiation by inhibiting Sox17 expression.","method":"Hoxa1 null ES cells, RA-induced differentiation protocol, marker expression analysis, Hoxa1 rescue by metallothionein-driven re-expression","journal":"Journal of neuroscience research","confidence":"Medium","confidence_rationale":"Tier 2 — loss-of-function and rescue experiment with defined cellular phenotype, single lab","pmids":["18512762"],"is_preprint":false},{"year":2010,"finding":"Hoxa1 lineage tracing using Hoxa1-IRES-Cre mice reveals that Hoxa1-expressing precursors contribute directly to the otic epithelium (except sensory patches), atria and outflow tract of the developing heart, and rhombomere 3—demonstrating broader direct roles for Hoxa1 than previously recognized.","method":"Cre-mediated lineage tracing (Hoxa1-IRES-Cre), reporter gene activation in mouse embryos","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 — direct in vivo lineage tracing experiment with functional consequence implications","pmids":["20171203"],"is_preprint":false},{"year":2011,"finding":"Hoxa1 null mice display cardiovascular defects including interrupted aortic arch, aberrant subclavian artery, and Tetralogy of Fallot; Hoxa1 is expressed in precursors of cardiac neural crest cells and acts upstream of genes controlling neural crest specification, indicating Hoxa1 regulates heart development via cardiac NCCs.","method":"Hoxa1 null mice, cardiac morphology analysis, gene expression analysis of NCC specification markers","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 — loss-of-function with defined phenotype and upstream pathway position established by marker analysis","pmids":["21940751"],"is_preprint":false},{"year":2011,"finding":"Histone demethylase KDM3A (JMJD1A) activates HOXA1 transcription by demethylating H3K9me2 at the HOXA1 promoter; KDM3A knockdown reduces HOXA1 and CCND1 levels causing G1 arrest, and KDM3A expression positively correlates with HOXA1 in cancer cell lines.","method":"siRNA knockdown of KDM3A, ChIP showing KDM3A binding to HOXA1 promoter, H3K9me2 demethylation assay, cell cycle analysis","journal":"International journal of cancer","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP-based mechanism with functional epistasis, single lab","pmids":["22020899"],"is_preprint":false},{"year":2011,"finding":"Microarray analysis of Hoxa1 null embryos identified downstream targets of Hoxa1 including Zic1, Hnf1b, Foxd3 (neural crest induction), Pax8 and Fgfr3 (inner ear), and Lhx5 (brainstem neurons), placing Hoxa1 upstream of these genes in a developmental genetic cascade.","method":"Microarray on microdissected Hoxa1 null vs. wild-type embryo tissue, gene expression validation","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 — genome-wide loss-of-function expression profiling with validation, single study","pmids":["21784065"],"is_preprint":false},{"year":2012,"finding":"Hoxa1 interacts with a broad network of proteins including components of cell-signaling transduction, cell adhesion, and vesicular trafficking, as identified by a systematic yeast two-hybrid screen against ~12,200 ORFs; 45 interactions confirmed by affinity co-purification, and 41 by Bimolecular Fluorescence Complementation revealing distinct intracellular localization patterns (vesicular, cytoplasmic, and nuclear compartments).","method":"Yeast two-hybrid screen, affinity co-purification in animal cell lines, Bimolecular Fluorescence Complementation","journal":"BMC developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 — systematic interactome with orthogonal validation methods, single lab","pmids":["23088713"],"is_preprint":false},{"year":2013,"finding":"The lncRNA linc-HOXA1, located ~50 kb from the Hoxa gene cluster, represses Hoxa1 transcription in cis by recruiting the protein PURB as a transcriptional cofactor; single-cell transcript counting shows anti-correlated expression of linc-HOXA1 and Hoxa1, and knockdown of linc-HOXA1 at its transcription site increases Hoxa1 transcription on the same chromosome. Retinoic acid disrupts this repression.","method":"Single-cell transcript counting, RNA FISH, siRNA knockdown, cis-acting analysis by allele-specific manipulation","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods including single-cell imaging and cis-specific knockdown, plus identification of PURB as cofactor","pmids":["23723417"],"is_preprint":false},{"year":2014,"finding":"ACK1 tyrosine kinase phosphorylates the histone demethylase KDM3A at tyrosine 1114 in a heregulin-dependent manner, decreasing H3K9me2 deposition and thereby increasing HOXA1 transcription; inhibition of ACK1 restores H3K9me2 marks and suppresses HOXA1 expression, conferring tamoxifen resistance.","method":"In vitro kinase assay, phospho-site mutagenesis, ChIP for H3K9me2, small-molecule ACK1 inhibitors (AIM-100, Dasatinib), siRNA knockdown","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — kinase assay with phospho-site mutagenesis, ChIP validation, and pharmacological epistasis","pmids":["25148682"],"is_preprint":false},{"year":2015,"finding":"YAP (Hippo pathway transcriptional coactivator) regulates Hoxa1 expression in oral and dental epithelial tissues; ChIP assay implicates TEAD transcription factors as mediators of YAP-driven Hoxa1 regulation, and sphere formation assays show Hoxa1 is functionally involved in YAP-regulated epithelial progenitor proliferation.","method":"RNA-Seq, in situ hybridization, ChIP (YAP/TEAD), sphere formation assay, Yap conditional knockout and transgenic mice","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP plus genetic loss- and gain-of-function with functional sphere assay, single lab","pmids":["25691658"],"is_preprint":false},{"year":2015,"finding":"Hoxa1 and Hoxb1 are expressed in a sub-population of second heart field progenitors contributing to the cardiac outflow tract; compound Hoxa1−/−; Hoxb1+/− embryos display outflow tract defects with premature SHF differentiation, demonstrating redundant roles for Hoxa1 and Hoxb1 in outflow tract development upstream of FGF/ERK and BMP/SMAD signaling.","method":"Compound mutant mice, SHF marker analysis, FGF/ERK and BMP/SMAD pathway analysis","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 — genetic epistasis in compound mutants with pathway analysis, single lab","pmids":["26284287"],"is_preprint":false},{"year":2016,"finding":"HOXA1 physically interacts with RBCK1/HOIL-1 and TRAF2 (TNFR-associated proteins) via its 11-His repeat and homeodomain, and activates NF-κB signaling upstream of IκB through a non-transcriptional mechanism; RBCK1 and TRAF2 influences on NF-κB are epistatic to HOXA1. NF-κB activation is required for HOXA1 oncogenic activity.","method":"Proteome-wide yeast two-hybrid, co-immunoprecipitation, reporter assays for NF-κB, domain deletion/mutagenesis, epistasis experiments","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1-2 — interactome screen validated by co-IP, domain mapping, and epistasis; non-transcriptional mechanism established","pmids":["27382069"],"is_preprint":false},{"year":2017,"finding":"Genome-wide Hoxa1 binding analysis in differentiating ES cells reveals that Hoxa1 is rapidly recruited to target sites co-occupied by Nanog; Hoxa1 binds regulatory regions of Nanog, and Nanog binds the 3' enhancer of Hoxa1, establishing direct cross-regulatory mutual repression between Hoxa1 and the core pluripotency network. Hoxa1 also binds regulatory regions of Sox2, Esrrb, and Myc.","method":"ChIP-seq, genome-wide occupancy mapping, expression analysis, retinoic acid-induced ES cell differentiation","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 — genome-wide ChIP-seq with reciprocal binding validation and functional consequence in differentiation, single lab","pmids":["28584089"],"is_preprint":false},{"year":2017,"finding":"Genome-wide Hoxa1 binding in differentiating ES cells maps to enhancer regions co-occupied by Hox cofactors; Hoxa1 targets multiple components of major signaling pathways (Wnt, TGF-β, Hedgehog, Hippo) and genes involved in neural crest migration, inner ear development, and heart development; two enhancers in Dok5 and Wls1 were validated for neural expression in mouse and zebrafish.","method":"ChIP-seq, differential gene expression analysis in Hoxa1 gain- and loss-of-function mouse and zebrafish, transgenic reporter assays","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 1-2 — genome-wide binding data cross-validated with multiple species and in vivo enhancer reporter assays","pmids":["28982536"],"is_preprint":false},{"year":2017,"finding":"KDM3B binds retinoic acid response elements (but not the promoter) of HOXA1 and demethylates H3K9 at those sites to transcriptionally activate HOXA1; KDM3B knockdown increases H3K9me1 but decreases H3K9me2 at the RARE region of HOXA1.","method":"KDM3B overexpression and knockdown, ChIP for KDM3B binding and H3K9 methylation marks, microarray profiling","journal":"Leukemia & lymphoma","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP-based mechanistic study showing site-specific histone demethylation, single lab","pmids":["28540746"],"is_preprint":false},{"year":2018,"finding":"The lncRNA HOTAIRM1 activates HOXA1 transcription in GBM by sequestering histone methyltransferases G9a (H3K9me2) and EZH2 (H3K27me3) and DNA methyltransferases (DNMT1, DNMT3b) away from the HOXA1 gene TSS, causing histone and DNA demethylation at that locus.","method":"ChIP assay for histone marks, RNA-ChIP for HOTAIRM1-protein interactions, bisulfite sequencing PCR for DNA methylation, HOTAIRM1 knockdown","journal":"Journal of experimental & clinical cancer research","confidence":"Medium","confidence_rationale":"Tier 2 — multiple epigenetic readouts with RNA-ChIP for direct protein recruitment, single lab","pmids":["30376874"],"is_preprint":false},{"year":2020,"finding":"The lncRNA HOTAIRM1 prevents PRC2 complex (EZH2) from binding the HOXA1 promoter and depositing H3K27me3, thereby maintaining HOXA1 expression in tamoxifen-resistant breast cancer cells; HOTAIRM1 directly interacts with EZH2.","method":"RNA immunoprecipitation (RIP) for HOTAIRM1-EZH2 interaction, ChIP for H3K27me3 at HOXA1 promoter, HOTAIRM1 knockdown","journal":"Journal of Cancer","confidence":"Medium","confidence_rationale":"Tier 2 — RIP and ChIP with functional knockdown, single lab","pmids":["32284737"],"is_preprint":false},{"year":2020,"finding":"LncRNA HotairM1 recruits EZH2 and SUZ12 to the HOXA1 promoter, inducing H3K27 trimethylation and epigenetic silencing of HOXA1; silencing of HOXA1 subsequently induces H3K27 acetylation at the Nanog enhancer, upregulating Nanog expression and promoting cancer stem cell self-renewal in a reciprocal HOXA1-Nanog loop.","method":"ChIP for H3K27me3 and H3K27ac, EZH2/SUZ12 recruitment assay, HOXA1 knockdown, Nanog expression analysis","journal":"Molecular therapy. Nucleic acids","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP-based mechanistic study with identified chromatin-modifying complex and downstream epigenetic consequence, single lab","pmids":["33230449"],"is_preprint":false},{"year":1994,"finding":"Hoxa1 homeodomain protein binds to a site approximately 60 bp upstream of the L1 neural cell adhesion molecule transcription start site, as demonstrated by in vitro DNA binding assays; this site is also recognized by Pax-6.","method":"In vitro DNA binding (gel shift/footprinting)","journal":"DNA and cell biology","confidence":"Low","confidence_rationale":"Tier 3 — single in vitro binding assay without functional follow-up for HOXA1 specifically","pmids":["7917011"],"is_preprint":false},{"year":2023,"finding":"HOXA1 transcriptionally activates NF-κB RelA (p65) and KLF4 in vascular smooth muscle cells, promoting VSMC-to-macrophage-like phenotypic transformation; HOXA1 knockdown in ApoE−/− mice reduces atherosclerotic plaque formation and VSMC transdifferentiation.","method":"AAV1-shHOXA1 knockdown in ApoE−/− mice, in vitro VSMC model, Western blot, ChIP (implied by transcriptional activation claim)","journal":"Molecular medicine (Cambridge, Mass.)","confidence":"Low","confidence_rationale":"Tier 3 — mechanistic claim of transcriptional activation of RelA and KLF4 not fully supported by direct ChIP evidence in abstract; single lab","pmids":["37528397"],"is_preprint":false}],"current_model":"HOXA1 is a homeodomain transcription factor that functions as a master regulator of early hindbrain patterning (rhombomere identity specification), acting upstream of Hoxb1, EphA2, and neural crest specification genes; it is directly activated by retinoic acid through a 3' RARE-containing enhancer (modulated by RAR/RXR, SUZ12/PRC2, and lncRNAs such as linc-HOXA1 and HOTAIRM1), cooperates with PBX cofactors through its YPWM motif to bind composite Hox-Pbx DNA sites, activates NF-κB via non-transcriptional interaction with RBCK1/HOIL-1 and TRAF2, promotes cell survival through Bcl-2 and MAP kinase pathway upregulation in mammary epithelial cells, and is epigenetically regulated by histone demethylases KDM3A and KDM3B acting on H3K9 marks at its promoter/RARE regions."},"narrative":{"teleology":[{"year":1991,"claim":"Establishing that Hoxa1 is essential for hindbrain segmentation resolved the question of whether individual Hox genes have non-redundant roles in anteroposterior patterning, revealing that Hoxa1 loss causes rhombomere 4–7 defects, cranial nerve agenesis, and inner ear malformations.","evidence":"Homologous recombination gene targeting producing Hoxa1 null mice in two independent labs","pmids":["1680563","1346922"],"confidence":"High","gaps":["Direct transcriptional targets of Hoxa1 in the hindbrain were unknown","Whether Hoxa1 acts cell-autonomously was not established","Cofactor requirements for Hoxa1 DNA binding were undefined"]},{"year":1992,"claim":"Identifying a 3′ retinoic acid response element–containing enhancer established how RA directly activates Hoxa1 transcription, placing Hoxa1 as a primary RA-responsive gene in the Hox cascade.","evidence":"DNase I hypersensitivity mapping, lacZ reporter transgenic mice, RARE point mutations in F9 cells and in vivo","pmids":["1360810","7743939"],"confidence":"High","gaps":["The identity of trans-acting factors beyond RAR/RXR at the enhancer was unknown","Epigenetic regulation of the RARE locus had not been explored"]},{"year":1998,"claim":"Demonstrating that the YPWM motif mediates cooperative DNA binding with PBX cofactors, and that HOXA1/PBX1/HOXB1 activate EphA2 and the Hoxb1 autoregulatory enhancer, defined the molecular logic by which Hoxa1 engages its transcriptional targets in hindbrain patterning.","evidence":"EMSA with YPWM mutagenesis, co-transfection reporter assays, transgenic embryo analysis, Hoxa1/Hoxb1 double-mutant mice","pmids":["9582372","9733765","11278854"],"confidence":"High","gaps":["Genome-wide binding sites for HOXA1 were unknown","Whether homeodomain residue differences between paralogs affect target selection in vivo was untested"]},{"year":1998,"claim":"Compound Hoxa1/Hoxb1 double-mutant analyses revealed overlapping paralog functions in rhombomere 4/5 identity, second arch formation, and ear development that are cryptic in single mutants, establishing the genetic redundancy framework for Hox1 paralogs.","evidence":"Double knockout mice with neurofilament staining, retrograde labeling, molecular marker analysis","pmids":["9463359","9463349","10529420","10662633"],"confidence":"High","gaps":["Whether functional redundancy reflects protein equivalence or regulatory overlap was unresolved","Cell-autonomous versus non-cell-autonomous contributions were not distinguished"]},{"year":2001,"claim":"Cell-autonomous requirement for Hoxa1/Hoxb1 in neural crest generation from r4 was established through grafting experiments, showing that Hoxa1 acts within neuroepithelium to specify neural crest competence rather than through secondary signaling.","evidence":"Ectoderm-specific double-mutant mice, grafting experiments in cultured embryos, lineage analysis","pmids":["11532923"],"confidence":"High","gaps":["Direct neural crest gene targets of Hoxa1 were not identified","How Hoxa1 interfaces with neural crest induction pathways (Foxd3, Sox9) was mechanistically unclear"]},{"year":2002,"claim":"Protein-swap knock-in experiments showed that HOXA1 and HOXB1 coding sequences are functionally interchangeable, demonstrating that paralog subfunctionalization is driven by regulatory element divergence rather than protein sequence differences.","evidence":"Knock-in mice with swapped coding regions, insertion of Hoxb1 autoregulatory enhancer into Hoxa1 locus","pmids":["16890163"],"confidence":"High","gaps":["Whether this interchangeability extends beyond hindbrain patterning to other tissues was not tested","Post-translational modifications distinguishing paralogs were not addressed"]},{"year":2002,"claim":"Discovery that forced HOXA1 expression transforms mammary epithelial cells via Bcl-2 upregulation and survival signaling expanded HOXA1 function beyond developmental patterning into oncogenic contexts.","evidence":"Forced expression in mammary cells, soft agar assays, tumor formation, Bcl-2 reporter assays","pmids":["12482855"],"confidence":"Medium","gaps":["Whether Bcl-2 is a direct transcriptional target (Hoxa1 binding at Bcl-2 regulatory regions) was not confirmed by ChIP","Relevance to endogenous breast cancer was correlative"]},{"year":2007,"claim":"Placing HOXA1 upstream of the p44/42 MAPK pathway through transcriptional activation of GRB2 and MEK1 defined the signaling axis through which HOXA1 promotes proliferation and transformation, with MEK inhibition blocking HOXA1 oncogenic activity.","evidence":"Microarray profiling, HOXA1 forced expression/depletion, MEK1 inhibitor epistasis, Western blot","pmids":["17213808"],"confidence":"Medium","gaps":["Direct binding of HOXA1 to GRB2/MEK1 regulatory regions was not shown","In vivo relevance of the MAPK axis in HOXA1-driven tumors was not tested"]},{"year":2007,"claim":"Revealing that SUZ12/PRC2 occupies the Hoxa1 RARE before RA treatment and is displaced upon RA exposure established the Polycomb-to-activation chromatin switch governing Hoxa1 induction, linking epigenetic silencing to the RA signaling response.","evidence":"ChIP for SUZ12, H3K27me3, H3ac, H3K4me2, and RNA Pol II in F9 embryonal carcinoma cells ± RA","pmids":["17663992"],"confidence":"Medium","gaps":["The mechanism of PRC2 displacement was unknown","Whether additional chromatin remodelers participate was not tested"]},{"year":2010,"claim":"Lineage tracing with Hoxa1-IRES-Cre revealed that Hoxa1-expressing cells contribute directly to the otic epithelium, cardiac atria, outflow tract, and rhombomere 3, expanding the known developmental domains of Hoxa1 beyond the hindbrain.","evidence":"Cre-mediated lineage tracing in mouse embryos","pmids":["20171203"],"confidence":"High","gaps":["Functional requirement for Hoxa1 in cardiac and otic lineages was not established in this study","Whether contributions to r3 reflect early transient expression was unclear"]},{"year":2011,"claim":"Characterization of cardiovascular defects in Hoxa1 nulls (interrupted aortic arch, Tetralogy of Fallot) and identification of downstream targets (Zic1, Foxd3, Hnf1b, Pax8) by microarray placed Hoxa1 as a regulator of cardiac neural crest specification and defined its developmental gene network.","evidence":"Hoxa1 null cardiac phenotyping, microarray on microdissected embryonic tissue, compound mutant analysis with Hoxb1","pmids":["21940751","21784065","26284287"],"confidence":"High","gaps":["Direct binding of Hoxa1 to these downstream target promoters/enhancers was not shown","Functional rescue experiments for individual targets were not performed"]},{"year":2013,"claim":"Discovery that lncRNA linc-HOXA1 represses Hoxa1 in cis by recruiting PURB established a novel regulatory layer operating at the single-chromosome level, with RA overriding this repression during differentiation.","evidence":"Single-cell transcript counting, RNA FISH, allele-specific siRNA knockdown, PURB identification","pmids":["23723417"],"confidence":"High","gaps":["The mechanism by which PURB mediates transcriptional repression was undefined","Whether linc-HOXA1 regulation operates in vivo during embryogenesis was not shown"]},{"year":2014,"claim":"Identification of ACK1-mediated phosphorylation of KDM3A (Y1114) as an activating signal for H3K9 demethylation at the HOXA1 promoter linked receptor tyrosine kinase signaling to HOXA1 epigenetic de-repression, connecting growth factor signaling with HOXA1 transcriptional control.","evidence":"In vitro kinase assay, phospho-site mutagenesis, ChIP for H3K9me2, pharmacological inhibitors","pmids":["25148682"],"confidence":"High","gaps":["Whether this ACK1-KDM3A-HOXA1 axis operates during normal development was not tested","Additional substrates of ACK1 at the HOXA1 locus were not explored"]},{"year":2016,"claim":"Demonstrating that HOXA1 activates NF-κB signaling non-transcriptionally through physical interaction with RBCK1/HOIL-1 and TRAF2 via its His-repeat and homeodomain revealed an unexpected cytoplasmic signaling function for a homeodomain transcription factor, required for its oncogenic activity.","evidence":"Yeast two-hybrid, co-immunoprecipitation, NF-κB reporter assays, domain deletion/mutagenesis, epistasis experiments","pmids":["27382069"],"confidence":"High","gaps":["Whether HOXA1-RBCK1/TRAF2 complexes form in physiological developmental contexts was untested","The stoichiometry and dynamics of HOXA1 partitioning between nuclear and cytoplasmic functions were unknown"]},{"year":2017,"claim":"Genome-wide ChIP-seq in differentiating ES cells mapped Hoxa1 occupancy to enhancers co-bound by Nanog and Hox cofactors, establishing direct cross-regulatory repression between Hoxa1 and the pluripotency network and defining HOXA1's genome-wide target repertoire across Wnt, TGF-β, Hedgehog, and Hippo pathway genes.","evidence":"ChIP-seq in RA-treated ES cells, reciprocal binding analysis, cross-species validation in mouse and zebrafish transgenic reporters","pmids":["28584089","28982536"],"confidence":"High","gaps":["Functional validation of individual enhancer targets beyond Dok5 and Wls1 was limited","Time-resolved binding dynamics during the RA response were not captured"]},{"year":2018,"claim":"Studies in cancer cells showed that lncRNA HOTAIRM1 modulates HOXA1 expression bidirectionally — activating it in glioblastoma by sequestering G9a, EZH2, and DNMTs away from the TSS, and in other contexts recruiting EZH2/SUZ12 to silence it — revealing context-dependent epigenetic regulation of HOXA1 by the same lncRNA.","evidence":"RNA-ChIP, ChIP for H3K9me2/H3K27me3, bisulfite sequencing, RIP for HOTAIRM1-EZH2, HOTAIRM1 knockdown","pmids":["30376874","32284737","33230449"],"confidence":"Medium","gaps":["Contradictory roles of HOTAIRM1 (activating vs. silencing HOXA1) in different cell types were not reconciled mechanistically","In vivo developmental relevance of HOTAIRM1-HOXA1 regulation was not established"]},{"year":null,"claim":"The structural basis for HOXA1's dual nuclear (transcription factor) and cytoplasmic (NF-κB activation) functions, and how cells partition HOXA1 between these roles during development versus oncogenesis, remains unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No crystal or cryo-EM structure of HOXA1 alone or in complex with PBX/RBCK1","Mechanism by which HOXA1 partitions between transcriptional and non-transcriptional functions is unknown","Whether HOXA1's NF-κB activation has any developmental role has not been tested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[3,7,12,28,29,34]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[3,5,6,13,15,28,29]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[27]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[3,7,12,22,28,29]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[22,27]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[1,2,3,5,13,15,28,29]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[0,4,6,8,9,18,19,26]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[15,27,29]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[16,20,24,30,31,32,33]}],"complexes":[],"partners":["PBX1","HOXB1","RBCK1","TRAF2","KDM3A","PURB","EZH2","SUZ12"],"other_free_text":[]},"mechanistic_narrative":"HOXA1 is a homeodomain transcription factor that serves as a master regulator of early hindbrain patterning, neural crest specification, and cardiac outflow tract development, acting as a primary transducer of retinoic acid signaling during embryogenesis. HOXA1 cooperates with PBX cofactors through its YPWM motif to bind composite Hox-Pbx DNA sites, directly activating targets including EphA2 and the Hoxb1 autoregulatory enhancer, and synergizes with HOXB1 to specify rhombomere 4/5 identity and generate cranial neural crest cells [PMID:1680563, PMID:9733765, PMID:9463359, PMID:11532923]. Its transcription is induced by retinoic acid through a 3′ RARE-containing enhancer and is epigenetically modulated by Polycomb (SUZ12/EZH2-mediated H3K27me3), H3K9 demethylases KDM3A and KDM3B, and lncRNAs linc-HOXA1 and HOTAIRM1 that regulate chromatin modifier access at the HOXA1 locus [PMID:1360810, PMID:17663992, PMID:23723417, PMID:25148682, PMID:30376874]. Beyond its canonical transcriptional roles, HOXA1 activates NF-κB signaling through a non-transcriptional mechanism involving physical interaction with RBCK1/HOIL-1 and TRAF2, and promotes oncogenic transformation of mammary epithelial cells by upregulating Bcl-2 and the p44/42 MAPK pathway [PMID:27382069, PMID:12482855, PMID:17213808]."},"prefetch_data":{"uniprot":{"accession":"P49639","full_name":"Homeobox protein Hox-A1","aliases":["Homeobox protein Hox-1F"],"length_aa":335,"mass_kda":36.7,"function":"Sequence-specific transcription factor (By similarity). Regulates multiple developmental processes including brainstem, inner and outer ear, abducens nerve and cardiovascular development and morphogenesis as well as cognition and behavior (PubMed:16155570). Also part of a developmental regulatory system that provides cells with specific positional identities on the anterior-posterior axis. Acts on the anterior body structures. Seems to act in the maintenance and/or generation of hindbrain segments (By similarity). Activates transcription in the presence of PBX1A and PKNOX1 (By similarity)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/P49639/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/HOXA1","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/HOXA1","total_profiled":1310},"omim":[{"mim_id":"620163","title":"ZFP14 ZINC FINGER PROTEIN; ZFP14","url":"https://www.omim.org/entry/620163"},{"mim_id":"618813","title":"TUBULIN TYROSINE LIGASE-LIKE 7; TTLL7","url":"https://www.omim.org/entry/618813"},{"mim_id":"617649","title":"UBIQUITIN-CONJUGATING ENZYME E2 O; UBE2O","url":"https://www.omim.org/entry/617649"},{"mim_id":"617346","title":"ATP/GTP-BINDING PROTEIN-LIKE 3; AGBL3","url":"https://www.omim.org/entry/617346"},{"mim_id":"617041","title":"DUANE RETRACTION SYNDROME 3 WITH OR WITHOUT DEAFNESS; DURS3","url":"https://www.omim.org/entry/617041"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"urinary bladder","ntpm":5.0}],"url":"https://www.proteinatlas.org/search/HOXA1"},"hgnc":{"alias_symbol":[],"prev_symbol":["HOX1F","HOX1"]},"alphafold":{"accession":"P49639","domains":[{"cath_id":"1.10.10.60","chopping":"237-292","consensus_level":"medium","plddt":96.5784,"start":237,"end":292}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P49639","model_url":"https://alphafold.ebi.ac.uk/files/AF-P49639-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P49639-F1-predicted_aligned_error_v6.png","plddt_mean":57.78},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=HOXA1","jax_strain_url":"https://www.jax.org/strain/search?query=HOXA1"},"sequence":{"accession":"P49639","fasta_url":"https://rest.uniprot.org/uniprotkb/P49639.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P49639/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P49639"}},"corpus_meta":[{"pmid":"1673020","id":"PMC_1673020","title":"Regionally restricted developmental defects resulting from targeted disruption of the mouse homeobox gene hox-1.5.","date":"1991","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/1673020","citation_count":755,"is_preprint":false},{"pmid":"1680563","id":"PMC_1680563","title":"Disruption of the Hox-1.6 homeobox gene results in defects in a region corresponding to its rostral domain of expression.","date":"1991","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/1680563","citation_count":637,"is_preprint":false},{"pmid":"1346922","id":"PMC_1346922","title":"Developmental defects of the ear, cranial nerves and hindbrain resulting from targeted disruption of the mouse homeobox gene Hox-1.6.","date":"1992","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/1346922","citation_count":481,"is_preprint":false},{"pmid":"1970515","id":"PMC_1970515","title":"Variations of cervical vertebrae after expression of a Hox-1.1 transgene in mice.","date":"1990","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/1970515","citation_count":347,"is_preprint":false},{"pmid":"9463359","id":"PMC_9463359","title":"Hoxa1 and Hoxb1 synergize in patterning the hindbrain, cranial nerves and second pharyngeal arch.","date":"1998","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/9463359","citation_count":261,"is_preprint":false},{"pmid":"9463349","id":"PMC_9463349","title":"Genetic interactions between Hoxa1 and Hoxb1 reveal new roles in regulation of early hindbrain patterning.","date":"1998","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/9463349","citation_count":252,"is_preprint":false},{"pmid":"1360810","id":"PMC_1360810","title":"Identification of a retinoic acid responsive enhancer 3' of the murine homeobox gene Hox-1.6.","date":"1992","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/1360810","citation_count":245,"is_preprint":false},{"pmid":"2568891","id":"PMC_2568891","title":"Craniofacial abnormalities induced by ectopic expression of the homeobox gene Hox-1.1 in transgenic mice.","date":"1989","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/2568891","citation_count":240,"is_preprint":false},{"pmid":"16155570","id":"PMC_16155570","title":"Homozygous HOXA1 mutations disrupt human brainstem, inner ear, cardiovascular and cognitive development.","date":"2005","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16155570","citation_count":214,"is_preprint":false},{"pmid":"1969796","id":"PMC_1969796","title":"The segment-specific gene Krox-20 encodes a transcription factor with binding sites in the promoter region of the Hox-1.4 gene.","date":"1990","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/1969796","citation_count":190,"is_preprint":false},{"pmid":"7743939","id":"PMC_7743939","title":"Evolutionary-conserved enhancers direct region-specific expression of the murine Hoxa-1 and Hoxa-2 loci in both mice and Drosophila.","date":"1995","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/7743939","citation_count":185,"is_preprint":false},{"pmid":"2563568","id":"PMC_2563568","title":"Transgenic mice overexpressing the mouse homoeobox-containing gene Hox-1.4 exhibit abnormal gut development.","date":"1989","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/2563568","citation_count":185,"is_preprint":false},{"pmid":"2576400","id":"PMC_2576400","title":"Mouse homeo-genes within a subfamily, Hox-1.4, -2.6 and -5.1, display similar anteroposterior domains of expression in the embryo, but show stage- and tissue-dependent differences in their regulation.","date":"1989","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/2576400","citation_count":184,"is_preprint":false},{"pmid":"7901120","id":"PMC_7901120","title":"Specification of axial identity in the mouse: role of the Hoxa-5 (Hox1.3) gene.","date":"1993","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/7901120","citation_count":167,"is_preprint":false},{"pmid":"10529420","id":"PMC_10529420","title":"Mice mutant for both Hoxa1 and Hoxb1 show extensive remodeling of the hindbrain and defects in craniofacial development.","date":"1999","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/10529420","citation_count":163,"is_preprint":false},{"pmid":"8631251","id":"PMC_8631251","title":"Ectopic expression of Hoxa-1 in the zebrafish alters the fate of the mandibular arch neural crest and phenocopies a retinoic acid-induced phenotype.","date":"1996","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/8631251","citation_count":162,"is_preprint":false},{"pmid":"10662633","id":"PMC_10662633","title":"Roles of Hoxa1 and Hoxa2 in patterning the early hindbrain of the mouse.","date":"2000","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/10662633","citation_count":141,"is_preprint":false},{"pmid":"30376874","id":"PMC_30376874","title":"Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme.","date":"2018","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/30376874","citation_count":138,"is_preprint":false},{"pmid":"2904354","id":"PMC_2904354","title":"Mouse homeobox gene transcripts occupy different but overlapping domains in embryonic germ layers and organs: a comparison of Hox-3.1 and Hox-1.5.","date":"1988","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/2904354","citation_count":134,"is_preprint":false},{"pmid":"8099045","id":"PMC_8099045","title":"The establishment of murine Hox-1 expression domains during patterning of the limb.","date":"1993","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/8099045","citation_count":131,"is_preprint":false},{"pmid":"2565857","id":"PMC_2565857","title":"The Hox-1.3 homeo box protein is a sequence-specific DNA-binding phosphoprotein.","date":"1989","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/2565857","citation_count":130,"is_preprint":false},{"pmid":"12482855","id":"PMC_12482855","title":"Human growth hormone-regulated HOXA1 is a human mammary epithelial oncogene.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12482855","citation_count":127,"is_preprint":false},{"pmid":"2891503","id":"PMC_2891503","title":"Hox-1.6: a mouse homeo-box-containing gene member of the Hox-1 complex.","date":"1987","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/2891503","citation_count":118,"is_preprint":false},{"pmid":"17663992","id":"PMC_17663992","title":"Retinoid regulated association of transcriptional co-regulators and the polycomb group protein SUZ12 with the retinoic acid response elements of Hoxa1, RARbeta(2), and Cyp26A1 in F9 embryonal carcinoma cells.","date":"2007","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/17663992","citation_count":112,"is_preprint":false},{"pmid":"23723417","id":"PMC_23723417","title":"linc-HOXA1 is a noncoding RNA that represses Hoxa1 transcription in cis.","date":"2013","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/23723417","citation_count":111,"is_preprint":false},{"pmid":"11091361","id":"PMC_11091361","title":"Discovery of allelic variants of HOXA1 and HOXB1: genetic susceptibility to autism spectrum disorders.","date":"2000","source":"Teratology","url":"https://pubmed.ncbi.nlm.nih.gov/11091361","citation_count":110,"is_preprint":false},{"pmid":"8095481","id":"PMC_8095481","title":"The mouse Hox-1.3 gene is functionally equivalent to the Drosophila Sex combs reduced gene.","date":"1993","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/8095481","citation_count":110,"is_preprint":false},{"pmid":"24559685","id":"PMC_24559685","title":"Downregulation of HOXA1 gene affects small cell lung cancer cell survival and chemoresistance under the regulation of miR-100.","date":"2014","source":"European journal of cancer (Oxford, England : 1990)","url":"https://pubmed.ncbi.nlm.nih.gov/24559685","citation_count":102,"is_preprint":false},{"pmid":"1685116","id":"PMC_1685116","title":"Separate elements cause lineage restriction and specify boundaries of Hox-1.1 expression.","date":"1991","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/1685116","citation_count":101,"is_preprint":false},{"pmid":"2576648","id":"PMC_2576648","title":"The mouse Hox-1.4 gene: primary structure, evidence for promoter activity and expression during development.","date":"1989","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/2576648","citation_count":101,"is_preprint":false},{"pmid":"2452725","id":"PMC_2452725","title":"Homoeobox gene Hox-1.5 expression in mouse embryos: earliest detection by in situ hybridization is during gastrulation.","date":"1987","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/2452725","citation_count":98,"is_preprint":false},{"pmid":"29662483","id":"PMC_29662483","title":"Long Non-Coding RNA HOXA Transcript Antisense RNA Myeloid-Specific 1-HOXA1 Axis Downregulates the Immunosuppressive Activity of Myeloid-Derived Suppressor Cells in Lung Cancer.","date":"2018","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/29662483","citation_count":97,"is_preprint":false},{"pmid":"7851655","id":"PMC_7851655","title":"Regulation of the Xenopus labial homeodomain genes, HoxA1 and HoxD1: activation by retinoids and peptide growth factors.","date":"1995","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/7851655","citation_count":97,"is_preprint":false},{"pmid":"22407312","id":"PMC_22407312","title":"MicroRNA-10a is overexpressed in human pancreatic cancer and involved in its invasiveness partially via suppression of the HOXA1 gene.","date":"2012","source":"Annals of surgical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/22407312","citation_count":94,"is_preprint":false},{"pmid":"14522873","id":"PMC_14522873","title":"Neuronal defects in the hindbrain of Hoxa1, Hoxb1 and Hoxb2 mutants reflect regulatory interactions among these Hox genes.","date":"2003","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/14522873","citation_count":94,"is_preprint":false},{"pmid":"26707824","id":"PMC_26707824","title":"Long noncoding RNA-HOTAIR affects chemoresistance by regulating HOXA1 methylation in small cell lung cancer cells.","date":"2015","source":"Laboratory investigation; a journal of technical methods and pathology","url":"https://pubmed.ncbi.nlm.nih.gov/26707824","citation_count":93,"is_preprint":false},{"pmid":"8100763","id":"PMC_8100763","title":"Sequences 5' of the homeobox of the Hox-1.4 gene direct tissue-specific expression of lacZ during mouse development.","date":"1993","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/8100763","citation_count":91,"is_preprint":false},{"pmid":"9733765","id":"PMC_9733765","title":"An enhancer element in the EphA2 (Eck) gene sufficient for rhombomere-specific expression is activated by HOXA1 and HOXB1 homeobox proteins.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9733765","citation_count":91,"is_preprint":false},{"pmid":"11532923","id":"PMC_11532923","title":"Synergy between Hoxa1 and Hoxb1: the relationship between arch patterning and the generation of cranial neural crest.","date":"2001","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11532923","citation_count":89,"is_preprint":false},{"pmid":"15576409","id":"PMC_15576409","title":"Retinoic acid signaling acts via Hox1 to establish the posterior limit of the pharynx in the chordate amphioxus.","date":"2004","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/15576409","citation_count":88,"is_preprint":false},{"pmid":"22020899","id":"PMC_22020899","title":"The JmjC domain-containing histone demethylase KDM3A is a positive regulator of the G1/S transition in cancer cells via transcriptional regulation of the HOXA1 gene.","date":"2011","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/22020899","citation_count":79,"is_preprint":false},{"pmid":"29228867","id":"PMC_29228867","title":"Long non-coding RNA CCAT1 promotes multiple myeloma progression by acting as a molecular sponge of miR-181a-5p to modulate HOXA1 expression.","date":"2018","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/29228867","citation_count":78,"is_preprint":false},{"pmid":"18412118","id":"PMC_18412118","title":"The clinical spectrum of homozygous HOXA1 mutations.","date":"2008","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/18412118","citation_count":78,"is_preprint":false},{"pmid":"7917011","id":"PMC_7917011","title":"Characterization of Pax-6 and Hoxa-1 binding to the promoter region of the neural cell adhesion molecule L1.","date":"1994","source":"DNA and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/7917011","citation_count":76,"is_preprint":false},{"pmid":"1971214","id":"PMC_1971214","title":"Position-specific activity of the Hox1.1 promoter in transgenic mice.","date":"1990","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/1971214","citation_count":75,"is_preprint":false},{"pmid":"21940751","id":"PMC_21940751","title":"Cardiovascular defects in a mouse model of HOXA1 syndrome.","date":"2011","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21940751","citation_count":75,"is_preprint":false},{"pmid":"16890163","id":"PMC_16890163","title":"Reversal of Hox1 gene subfunctionalization in the mouse.","date":"2006","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/16890163","citation_count":74,"is_preprint":false},{"pmid":"2891029","id":"PMC_2891029","title":"Murine Hox-1.7 homeo-box gene: cloning, chromosomal location, and expression.","date":"1987","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/2891029","citation_count":74,"is_preprint":false},{"pmid":"11466434","id":"PMC_11466434","title":"Generation of a novel functional neuronal circuit in Hoxa1 mutant mice.","date":"2001","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/11466434","citation_count":71,"is_preprint":false},{"pmid":"10529419","id":"PMC_10529419","title":"Compensatory defects associated with mutations in Hoxa1 restore normal palatogenesis to Hoxa2 mutants.","date":"1999","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/10529419","citation_count":68,"is_preprint":false},{"pmid":"24382894","id":"PMC_24382894","title":"Silencing HoxA1 by intraductal injection of siRNA lipidoid nanoparticles prevents mammary tumor progression in mice.","date":"2014","source":"Science translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/24382894","citation_count":67,"is_preprint":false},{"pmid":"2456573","id":"PMC_2456573","title":"Differential expression of the homeobox gene Hox-1.3 in F9 embryonal carcinoma cells.","date":"1988","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/2456573","citation_count":66,"is_preprint":false},{"pmid":"27382069","id":"PMC_27382069","title":"HOXA1 binds RBCK1/HOIL-1 and TRAF2 and modulates the TNF/NF-κB pathway in a transcription-independent manner.","date":"2016","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/27382069","citation_count":62,"is_preprint":false},{"pmid":"14960295","id":"PMC_14960295","title":"Association between the HOXA1 A218G polymorphism and increased head circumference in patients with autism.","date":"2004","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/14960295","citation_count":62,"is_preprint":false},{"pmid":"17875913","id":"PMC_17875913","title":"Clinical characterization of the HOXA1 syndrome BSAS variant.","date":"2007","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/17875913","citation_count":61,"is_preprint":false},{"pmid":"8670198","id":"PMC_8670198","title":"Detection of HOXA1 expression in human breast cancer.","date":"1996","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/8670198","citation_count":59,"is_preprint":false},{"pmid":"1352886","id":"PMC_1352886","title":"Murine Hox-1.11 homeobox gene structure and expression.","date":"1992","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/1352886","citation_count":59,"is_preprint":false},{"pmid":"25148682","id":"PMC_25148682","title":"ACK1 tyrosine kinase interacts with histone demethylase KDM3A to regulate the mammary tumor oncogene HOXA1.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25148682","citation_count":57,"is_preprint":false},{"pmid":"9806922","id":"PMC_9806922","title":"Hoxa1 and Krox-20 synergize to control the development of rhombomere 3.","date":"1998","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/9806922","citation_count":57,"is_preprint":false},{"pmid":"17213808","id":"PMC_17213808","title":"HOXA1-stimulated oncogenicity is mediated by selective upregulation of components of the p44/42 MAP kinase pathway in human mammary carcinoma cells.","date":"2007","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/17213808","citation_count":56,"is_preprint":false},{"pmid":"12799071","id":"PMC_12799071","title":"Expression of Raldh2, Cyp26 and Hox-1 in normal and retinoic acid-treated Ciona intestinalis embryos.","date":"2003","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/12799071","citation_count":56,"is_preprint":false},{"pmid":"30731321","id":"PMC_30731321","title":"miR-10a-5p Promotes Chondrocyte Apoptosis in Osteoarthritis by Targeting HOXA1.","date":"2018","source":"Molecular therapy. Nucleic acids","url":"https://pubmed.ncbi.nlm.nih.gov/30731321","citation_count":55,"is_preprint":false},{"pmid":"26135141","id":"PMC_26135141","title":"HOXA1 enhances the cell proliferation, invasion and metastasis of prostate cancer cells.","date":"2015","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/26135141","citation_count":53,"is_preprint":false},{"pmid":"11820809","id":"PMC_11820809","title":"Conserved regulation of the Caenorhabditis elegans labial/Hox1 gene ceh-13.","date":"2002","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/11820809","citation_count":53,"is_preprint":false},{"pmid":"11278854","id":"PMC_11278854","title":"The recruitment of SOX/OCT complexes and the differential activity of HOXA1 and HOXB1 modulate the Hoxb1 auto-regulatory enhancer function.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11278854","citation_count":53,"is_preprint":false},{"pmid":"20171203","id":"PMC_20171203","title":"Hoxa1 lineage tracing indicates a direct role for Hoxa1 in the development of the inner ear, the heart, and the third rhombomere.","date":"2010","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/20171203","citation_count":51,"is_preprint":false},{"pmid":"26417931","id":"PMC_26417931","title":"MicroRNA-99a inhibits tumor aggressive phenotypes through regulating HOXA1 in breast cancer cells.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26417931","citation_count":51,"is_preprint":false},{"pmid":"2887485","id":"PMC_2887485","title":"A mouse homeo box gene, Hox-1.5, and the morphological locus, Hd, map to within 1 cM on chromosome 6.","date":"1987","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/2887485","citation_count":49,"is_preprint":false},{"pmid":"9620166","id":"PMC_9620166","title":"Expression of Hoxa-1 and Hoxb-7 is regulated by extracellular matrix-dependent signals in mammary epithelial cells.","date":"1998","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9620166","citation_count":48,"is_preprint":false},{"pmid":"30596070","id":"PMC_30596070","title":"H3K27me3 induces multidrug resistance in small cell lung cancer by affecting HOXA1 DNA methylation via regulation of the lncRNA HOTAIR.","date":"2018","source":"Annals of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30596070","citation_count":47,"is_preprint":false},{"pmid":"21784065","id":"PMC_21784065","title":"Identification of novel Hoxa1 downstream targets regulating hindbrain, neural crest and inner ear development.","date":"2011","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/21784065","citation_count":47,"is_preprint":false},{"pmid":"28584089","id":"PMC_28584089","title":"Dynamic regulation of Nanog and stem cell-signaling pathways by Hoxa1 during early neuro-ectodermal differentiation of ES cells.","date":"2017","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/28584089","citation_count":45,"is_preprint":false},{"pmid":"30896864","id":"PMC_30896864","title":"circEIF4G2 modulates the malignant features of cervical cancer via the miR‑218/HOXA1 pathway.","date":"2019","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/30896864","citation_count":45,"is_preprint":false},{"pmid":"26284287","id":"PMC_26284287","title":"Hoxb1 regulates proliferation and differentiation of second heart field progenitors in pharyngeal mesoderm and genetically interacts with Hoxa1 during cardiac outflow tract development.","date":"2015","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/26284287","citation_count":45,"is_preprint":false},{"pmid":"1684419","id":"PMC_1684419","title":"Isolation and mapping of EVX1, a human homeobox gene homologous to even-skipped, localized at the 5' end of HOX1 locus on chromosome 7.","date":"1991","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/1684419","citation_count":45,"is_preprint":false},{"pmid":"23088713","id":"PMC_23088713","title":"Protein interactions of the transcription factor Hoxa1.","date":"2012","source":"BMC developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/23088713","citation_count":42,"is_preprint":false},{"pmid":"22573621","id":"PMC_22573621","title":"Retinoic acid-driven Hox1 is required in the epidermis for forming the otic/atrial placodes during ascidian metamorphosis.","date":"2012","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/22573621","citation_count":42,"is_preprint":false},{"pmid":"2895445","id":"PMC_2895445","title":"Genetic analysis and developmental regulation of testis-specific RNA expression of Mos, Abl, actin and Hox-1.4.","date":"1988","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/2895445","citation_count":42,"is_preprint":false},{"pmid":"32284737","id":"PMC_32284737","title":"The LncRNA HOTAIRM1 Promotes Tamoxifen Resistance by Mediating HOXA1 Expression in ER+ Breast Cancer Cells.","date":"2020","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/32284737","citation_count":41,"is_preprint":false},{"pmid":"32084702","id":"PMC_32084702","title":"lncRNA CCAT1 Acts as a MicroRNA-218 Sponge to Increase Gefitinib Resistance in NSCLC by Targeting HOXA1.","date":"2020","source":"Molecular therapy. Nucleic acids","url":"https://pubmed.ncbi.nlm.nih.gov/32084702","citation_count":39,"is_preprint":false},{"pmid":"32163893","id":"PMC_32163893","title":"lncRNA NEAT1 Binds to MiR-339-5p to Increase HOXA1 and Alleviate Ischemic Brain Damage in Neonatal Mice.","date":"2020","source":"Molecular therapy. Nucleic acids","url":"https://pubmed.ncbi.nlm.nih.gov/32163893","citation_count":38,"is_preprint":false},{"pmid":"16373333","id":"PMC_16373333","title":"HOXA1 is required for E-cadherin-dependent anchorage-independent survival of human mammary carcinoma cells.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16373333","citation_count":38,"is_preprint":false},{"pmid":"28982536","id":"PMC_28982536","title":"Hoxa1 targets signaling pathways during neural differentiation of ES cells and mouse embryogenesis.","date":"2017","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/28982536","citation_count":37,"is_preprint":false},{"pmid":"16989981","id":"PMC_16989981","title":"Induction of the homeotic gene Hoxa1 through valproic acid's teratogenic mechanism of action.","date":"2006","source":"Neurotoxicology and teratology","url":"https://pubmed.ncbi.nlm.nih.gov/16989981","citation_count":36,"is_preprint":false},{"pmid":"31853186","id":"PMC_31853186","title":"LncRNA HOTAIRM1/HOXA1 Axis Promotes Cell Proliferation, Migration And Invasion In Endometrial Cancer.","date":"2019","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/31853186","citation_count":35,"is_preprint":false},{"pmid":"25691658","id":"PMC_25691658","title":"YAP regulates the expression of Hoxa1 and Hoxc13 in mouse and human oral and skin epithelial tissues.","date":"2015","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/25691658","citation_count":35,"is_preprint":false},{"pmid":"16096791","id":"PMC_16096791","title":"Identification and linkage mapping of the genes for the putative homeodomain protein (hox1) and the putative pheromone receptor protein homologue (rcb1) in a bipolar basidiomycete, Pholiota nameko.","date":"2005","source":"Current genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16096791","citation_count":32,"is_preprint":false},{"pmid":"7488013","id":"PMC_7488013","title":"Retinoic acid induces three newly cloned HOXA1 transcripts in MCF7 breast cancer cells.","date":"1995","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/7488013","citation_count":32,"is_preprint":false},{"pmid":"11840501","id":"PMC_11840501","title":"Lack of association between HoxA1 and HoxB1 gene variants and autism in 110 multiplex families.","date":"2002","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11840501","citation_count":32,"is_preprint":false},{"pmid":"18512762","id":"PMC_18512762","title":"Hoxa1 is required for the retinoic acid-induced differentiation of embryonic stem cells into neurons.","date":"2008","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/18512762","citation_count":31,"is_preprint":false},{"pmid":"33230449","id":"PMC_33230449","title":"lncRNA HotairM1 Depletion Promotes Self-Renewal of Cancer Stem Cells through HOXA1-Nanog Regulation Loop.","date":"2020","source":"Molecular therapy. Nucleic acids","url":"https://pubmed.ncbi.nlm.nih.gov/33230449","citation_count":30,"is_preprint":false},{"pmid":"33328510","id":"PMC_33328510","title":"LncRNA HOTAIRM1 promotes MDSC expansion and suppressive functions through the HOXA1-miR124 axis during HCV infection.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/33328510","citation_count":30,"is_preprint":false},{"pmid":"12412013","id":"PMC_12412013","title":"Targeted insertion results in a rhombomere 2-specific Hoxa2 knockdown and ectopic activation of Hoxa1 expression.","date":"2002","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/12412013","citation_count":30,"is_preprint":false},{"pmid":"28540746","id":"PMC_28540746","title":"KDM3B shows tumor-suppressive activity and transcriptionally regulates HOXA1 through retinoic acid response elements in acute myeloid leukemia.","date":"2017","source":"Leukemia & lymphoma","url":"https://pubmed.ncbi.nlm.nih.gov/28540746","citation_count":30,"is_preprint":false},{"pmid":"9582372","id":"PMC_9582372","title":"A conserved C-terminal domain in PBX increases DNA binding by the PBX homeodomain and is not a primary site of contact for the YPWM motif of HOXA1.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9582372","citation_count":28,"is_preprint":false},{"pmid":"17203192","id":"PMC_17203192","title":"Relationship between COPD and polymorphisms of HOX-1 and mEPH in a Chinese population.","date":"2007","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/17203192","citation_count":28,"is_preprint":false},{"pmid":"12060683","id":"PMC_12060683","title":"Changing homeodomain residues 2 and 3 of Hoxa1 alters its activity in a cell-type and enhancer dependent manner.","date":"2002","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/12060683","citation_count":28,"is_preprint":false},{"pmid":"37528397","id":"PMC_37528397","title":"HOXA1 participates in VSMC-to-macrophage-like cell transformation via regulation of NF-κB p65 and KLF4: a potential mechanism of atherosclerosis pathogenesis.","date":"2023","source":"Molecular medicine (Cambridge, Mass.)","url":"https://pubmed.ncbi.nlm.nih.gov/37528397","citation_count":27,"is_preprint":false},{"pmid":"7680626","id":"PMC_7680626","title":"Conservation and divergence of patterns of expression and lineage-specific transcripts in orthologues and paralogues of the mouse Hox-1.4 gene.","date":"1993","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/7680626","citation_count":27,"is_preprint":false},{"pmid":"32364673","id":"PMC_32364673","title":"microRNA-100 functions as a tumor suppressor in non-small cell lung cancer via regulating epithelial-mesenchymal transition and Wnt/β-catenin by targeting HOXA1.","date":"2020","source":"Thoracic cancer","url":"https://pubmed.ncbi.nlm.nih.gov/32364673","citation_count":26,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":46105,"output_tokens":8285,"usd":0.131295},"stage2":{"model":"claude-opus-4-6","input_tokens":12116,"output_tokens":4360,"usd":0.25437},"total_usd":0.385665,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1991,\n      \"finding\": \"Targeted disruption of Hox-1.6 (Hoxa1) in mice causes defects in rhombomeres 4-7, including absence of cranial nerves and ganglia, and malformed inner ears and skull bones, demonstrating Hoxa1 is required for regional specification along the rostrocaudal axis in its most rostral domain of expression.\",\n      \"method\": \"Homologous recombination gene targeting in embryonic stem cells, mouse knockout\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — independently replicated in two separate knockout studies (PMID:1680563 and PMID:1346922) with defined phenotypic readouts\",\n      \"pmids\": [\"1680563\", \"1346922\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"A retinoic acid-responsive enhancer located 3' of the Hoxa1 gene (containing a RARE identical to that of RARbeta) is required for retinoic acid-induced transcriptional activation of Hoxa1; the RARE alone is insufficient and other sequences within the enhancer also contribute.\",\n      \"method\": \"DNase I hypersensitivity mapping, lacZ minigene reporter assays in transgenic mice, F9 teratocarcinoma cell transfection\",\n      \"journal\": \"Mechanisms of development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods including in vivo reporter assays and point-mutation analysis of the RARE in a single study\",\n      \"pmids\": [\"1360810\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"An evolutionarily conserved enhancer within the Hoxa1 locus containing a retinoic acid response element drives expression in neuroepithelium caudal to rhombomere 4; point mutations in the RARE abolish this expression, supporting a direct role for endogenous retinoids in Hoxa1 regulation and hindbrain patterning.\",\n      \"method\": \"Transgenic mouse reporter assays with RARE point mutations\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vivo reporter assay with mutagenesis\",\n      \"pmids\": [\"7743939\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"HOXA1 and HOXB1, together with cofactor PBX1, bind to Hox-Pbx consensus sites in the EphA2 enhancer and transcriptionally activate EphA2 expression; this is required for rhombomere 4-specific EphA2 expression in vivo, as EphA2 expression is reduced in Hoxa1/Hoxb1 double mutants.\",\n      \"method\": \"In vitro DNA binding (EMSA/co-immunoprecipitation), co-transfection reporter assays, transgenic embryo analysis, double-mutant mice\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro binding confirmed with in vivo genetic validation using double-mutant mice\",\n      \"pmids\": [\"9733765\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Hoxa1 and Hoxb1 genetically synergize to pattern the hindbrain, cranial nerves, and second pharyngeal arch; double null mutants show loss of all second arch-derived elements and complete disruption of ear development, phenotypes not seen in single mutants.\",\n      \"method\": \"Genetic epistasis via compound double-mutant mice, neurofilament staining, retrograde motor neuron labeling\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — two independent labs (PMID:9463359 and PMID:9463349) using double-mutant genetic analysis with multiple cellular phenotype readouts\",\n      \"pmids\": [\"9463359\", \"9463349\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Hoxa1 is the primary mediator of the retinoic acid response of the Hoxb1 autoregulatory enhancer (b1-ARE) in vivo; this function requires binding of SOX/OCT heterodimers to the b1-ARE. HOXA1 has significantly lower transcriptional activity than HOXB1 from the b1-ARE, with the differential activity mapped to the HOXB1 N-terminal transcriptional activation domain.\",\n      \"method\": \"Transgenic mice, cell transfection reporter assays, SOX/OCT site mutagenesis, analysis of Hoxa1 mutant mice\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — mechanistic domain mapping combined with in vivo transgenic and mutant mouse validation\",\n      \"pmids\": [\"11278854\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Hoxa1 is required to set the anterior limit of Hoxb1 expression at the r3/r4 boundary; loss of Hoxa1 initiates a cascade of gene misexpressions causing misspecification of hindbrain compartments r2 through r5, followed by ectopic apoptosis.\",\n      \"method\": \"Genetic epistasis via single and double knockout mice, molecular marker analysis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — double-mutant genetic epistasis with defined molecular cascade\",\n      \"pmids\": [\"10662633\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The YPWM motif of HOXA1 is strictly required for cooperative DNA binding with PBX cofactors in vitro and in vivo; the YPWM motif contacts the PBX homeodomain. The GKFQ domain of PBX increases DNA binding by PBX but is not a primary contact site for HOXA1's YPWM motif.\",\n      \"method\": \"In vitro DNA binding assays (EMSA), co-transfection, deletion/mutagenesis of E2A-PBX\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted binding assays with defined mutagenesis of interaction surfaces\",\n      \"pmids\": [\"9582372\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Hoxa1 and Hoxb1 double mutants show loss of both rhombomeres 4 and 5 and selective loss of the second branchial arch, demonstrating overlapping functions in rhombomere identity specification; the aberrant hindbrain subsequently undergoes size regulation through apoptosis.\",\n      \"method\": \"Double knockout mice, molecular marker analysis, histology\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — double-mutant genetic analysis with defined cellular and molecular phenotypes\",\n      \"pmids\": [\"10529420\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Hoxa1 synergizes with Hoxb1 to generate cranial neural crest cells from r4; loss of both genes in the neuroepithelium reduces r4 size and abolishes its ability to generate neural crest cells in a cell-autonomous manner.\",\n      \"method\": \"Ectoderm-specific double-mutant mice, molecular and lineage analysis, grafting experiments in cultured embryos\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cell-autonomous defect established by grafting experiments combined with genetic double-mutant analysis\",\n      \"pmids\": [\"11532923\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Ectopic neuronal groups established by misspecification in Hoxa1 null mice (from the r3-r4 level, including r2-identity progenitors) form a supernumerary functional neuronal circuit that integrates the respiratory rhythm-generating network at birth.\",\n      \"method\": \"Hoxa1 null mouse analysis, electrophysiology, neuroanatomical tracing\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — defined cellular phenotype with functional circuit validation, single study\",\n      \"pmids\": [\"11466434\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"HOXA1 is functionally interchangeable with HOXB1 when protein-coding sequences are swapped at the respective loci in mice, demonstrating that subfunctionalization of Hox1 paralogs is mediated primarily by divergence of transcriptional regulatory elements rather than protein sequence differences.\",\n      \"method\": \"Knock-in mouse lines with swapped coding regions, insertion of Hoxb1 autoregulatory enhancer into Hoxa1 locus\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — protein swap reconstitution in vivo with multiple genetic combinations tested\",\n      \"pmids\": [\"16890163\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Hoxa1 homeodomain residues 2 and 3 (asparagine and alanine, unusual compared to typical basic residues) function as specificity determinants when Hoxa1 acts as a monomer, but do not influence target specificity in Pbx1a-Hoxa1 heterodimers in vitro; however, on the Hoxb1 autoregulatory enhancer these residues can modulate Hoxa1 activity even in the presence of Pbx, in a cell-type-dependent manner.\",\n      \"method\": \"Site-directed mutagenesis, cell transfection reporter assays, in vitro DNA binding\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with mutagenesis, single study\",\n      \"pmids\": [\"12060683\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Forced HOXA1 expression in human mammary carcinoma cells upregulates Bcl-2 transcription, promotes cell survival, anchorage-independent growth, and oncogenic transformation of immortalized mammary epithelial cells with in vivo tumor formation.\",\n      \"method\": \"Forced expression in human mammary cells, soft agar colony formation, in vivo tumor formation, Bcl-2 reporter assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple functional assays in one lab; Bcl-2 as direct downstream target established by transcriptional assay\",\n      \"pmids\": [\"12482855\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"E-cadherin-mediated cell-cell contact increases HOXA1 expression in mammary carcinoma cells through Rac1 signaling; HOXA1 is required downstream of E-cadherin for anchorage-independent proliferation and survival.\",\n      \"method\": \"E-cadherin blocking antibody, EGTA treatment, calcium rescue, Rac1 inhibition, HOXA1 siRNA knockdown\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple pharmacological and genetic perturbations in a single lab study\",\n      \"pmids\": [\"16373333\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"HOXA1-mediated oncogenic transformation of mammary epithelial cells requires activation of the p44/42 MAP kinase pathway; HOXA1 transcriptionally upregulates GRB2 and MEK1 and increases ERK phosphorylation, and MEK1 inhibition blocks HOXA1-driven proliferation, survival, and transformation.\",\n      \"method\": \"Microarray gene expression profiling, forced expression/depletion of HOXA1, MEK1 inhibitor treatment, Western blot\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pathway placement by pharmacological epistasis combined with expression profiling, single lab\",\n      \"pmids\": [\"17213808\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Polycomb group protein SUZ12 associates with the Hoxa1 RARE prior to retinoic acid treatment; RA treatment attenuates SUZ12 association and decreases H3K27me3 at the Hoxa1 RARE, while increasing H3ac, H3K4me2, and RNA Pol II occupancy. RAR-gamma and RXR-alpha are present at the RARE before and during RA treatment.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP) in F9 embryonal carcinoma cells\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP with multiple histone marks and factors, single lab\",\n      \"pmids\": [\"17663992\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Hoxa1 is required for retinoic acid-induced neuronal differentiation of embryonic stem cells; Hoxa1 null ES cells fail to express neuronal markers and instead upregulate endodermal markers (Sox17); re-introduction of Hoxa1 rescues neuronal differentiation. Hoxa1 may promote neural differentiation by inhibiting Sox17 expression.\",\n      \"method\": \"Hoxa1 null ES cells, RA-induced differentiation protocol, marker expression analysis, Hoxa1 rescue by metallothionein-driven re-expression\",\n      \"journal\": \"Journal of neuroscience research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function and rescue experiment with defined cellular phenotype, single lab\",\n      \"pmids\": [\"18512762\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Hoxa1 lineage tracing using Hoxa1-IRES-Cre mice reveals that Hoxa1-expressing precursors contribute directly to the otic epithelium (except sensory patches), atria and outflow tract of the developing heart, and rhombomere 3—demonstrating broader direct roles for Hoxa1 than previously recognized.\",\n      \"method\": \"Cre-mediated lineage tracing (Hoxa1-IRES-Cre), reporter gene activation in mouse embryos\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct in vivo lineage tracing experiment with functional consequence implications\",\n      \"pmids\": [\"20171203\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Hoxa1 null mice display cardiovascular defects including interrupted aortic arch, aberrant subclavian artery, and Tetralogy of Fallot; Hoxa1 is expressed in precursors of cardiac neural crest cells and acts upstream of genes controlling neural crest specification, indicating Hoxa1 regulates heart development via cardiac NCCs.\",\n      \"method\": \"Hoxa1 null mice, cardiac morphology analysis, gene expression analysis of NCC specification markers\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function with defined phenotype and upstream pathway position established by marker analysis\",\n      \"pmids\": [\"21940751\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Histone demethylase KDM3A (JMJD1A) activates HOXA1 transcription by demethylating H3K9me2 at the HOXA1 promoter; KDM3A knockdown reduces HOXA1 and CCND1 levels causing G1 arrest, and KDM3A expression positively correlates with HOXA1 in cancer cell lines.\",\n      \"method\": \"siRNA knockdown of KDM3A, ChIP showing KDM3A binding to HOXA1 promoter, H3K9me2 demethylation assay, cell cycle analysis\",\n      \"journal\": \"International journal of cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP-based mechanism with functional epistasis, single lab\",\n      \"pmids\": [\"22020899\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Microarray analysis of Hoxa1 null embryos identified downstream targets of Hoxa1 including Zic1, Hnf1b, Foxd3 (neural crest induction), Pax8 and Fgfr3 (inner ear), and Lhx5 (brainstem neurons), placing Hoxa1 upstream of these genes in a developmental genetic cascade.\",\n      \"method\": \"Microarray on microdissected Hoxa1 null vs. wild-type embryo tissue, gene expression validation\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genome-wide loss-of-function expression profiling with validation, single study\",\n      \"pmids\": [\"21784065\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Hoxa1 interacts with a broad network of proteins including components of cell-signaling transduction, cell adhesion, and vesicular trafficking, as identified by a systematic yeast two-hybrid screen against ~12,200 ORFs; 45 interactions confirmed by affinity co-purification, and 41 by Bimolecular Fluorescence Complementation revealing distinct intracellular localization patterns (vesicular, cytoplasmic, and nuclear compartments).\",\n      \"method\": \"Yeast two-hybrid screen, affinity co-purification in animal cell lines, Bimolecular Fluorescence Complementation\",\n      \"journal\": \"BMC developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — systematic interactome with orthogonal validation methods, single lab\",\n      \"pmids\": [\"23088713\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"The lncRNA linc-HOXA1, located ~50 kb from the Hoxa gene cluster, represses Hoxa1 transcription in cis by recruiting the protein PURB as a transcriptional cofactor; single-cell transcript counting shows anti-correlated expression of linc-HOXA1 and Hoxa1, and knockdown of linc-HOXA1 at its transcription site increases Hoxa1 transcription on the same chromosome. Retinoic acid disrupts this repression.\",\n      \"method\": \"Single-cell transcript counting, RNA FISH, siRNA knockdown, cis-acting analysis by allele-specific manipulation\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including single-cell imaging and cis-specific knockdown, plus identification of PURB as cofactor\",\n      \"pmids\": [\"23723417\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"ACK1 tyrosine kinase phosphorylates the histone demethylase KDM3A at tyrosine 1114 in a heregulin-dependent manner, decreasing H3K9me2 deposition and thereby increasing HOXA1 transcription; inhibition of ACK1 restores H3K9me2 marks and suppresses HOXA1 expression, conferring tamoxifen resistance.\",\n      \"method\": \"In vitro kinase assay, phospho-site mutagenesis, ChIP for H3K9me2, small-molecule ACK1 inhibitors (AIM-100, Dasatinib), siRNA knockdown\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — kinase assay with phospho-site mutagenesis, ChIP validation, and pharmacological epistasis\",\n      \"pmids\": [\"25148682\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"YAP (Hippo pathway transcriptional coactivator) regulates Hoxa1 expression in oral and dental epithelial tissues; ChIP assay implicates TEAD transcription factors as mediators of YAP-driven Hoxa1 regulation, and sphere formation assays show Hoxa1 is functionally involved in YAP-regulated epithelial progenitor proliferation.\",\n      \"method\": \"RNA-Seq, in situ hybridization, ChIP (YAP/TEAD), sphere formation assay, Yap conditional knockout and transgenic mice\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP plus genetic loss- and gain-of-function with functional sphere assay, single lab\",\n      \"pmids\": [\"25691658\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Hoxa1 and Hoxb1 are expressed in a sub-population of second heart field progenitors contributing to the cardiac outflow tract; compound Hoxa1−/−; Hoxb1+/− embryos display outflow tract defects with premature SHF differentiation, demonstrating redundant roles for Hoxa1 and Hoxb1 in outflow tract development upstream of FGF/ERK and BMP/SMAD signaling.\",\n      \"method\": \"Compound mutant mice, SHF marker analysis, FGF/ERK and BMP/SMAD pathway analysis\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis in compound mutants with pathway analysis, single lab\",\n      \"pmids\": [\"26284287\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"HOXA1 physically interacts with RBCK1/HOIL-1 and TRAF2 (TNFR-associated proteins) via its 11-His repeat and homeodomain, and activates NF-κB signaling upstream of IκB through a non-transcriptional mechanism; RBCK1 and TRAF2 influences on NF-κB are epistatic to HOXA1. NF-κB activation is required for HOXA1 oncogenic activity.\",\n      \"method\": \"Proteome-wide yeast two-hybrid, co-immunoprecipitation, reporter assays for NF-κB, domain deletion/mutagenesis, epistasis experiments\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — interactome screen validated by co-IP, domain mapping, and epistasis; non-transcriptional mechanism established\",\n      \"pmids\": [\"27382069\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Genome-wide Hoxa1 binding analysis in differentiating ES cells reveals that Hoxa1 is rapidly recruited to target sites co-occupied by Nanog; Hoxa1 binds regulatory regions of Nanog, and Nanog binds the 3' enhancer of Hoxa1, establishing direct cross-regulatory mutual repression between Hoxa1 and the core pluripotency network. Hoxa1 also binds regulatory regions of Sox2, Esrrb, and Myc.\",\n      \"method\": \"ChIP-seq, genome-wide occupancy mapping, expression analysis, retinoic acid-induced ES cell differentiation\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — genome-wide ChIP-seq with reciprocal binding validation and functional consequence in differentiation, single lab\",\n      \"pmids\": [\"28584089\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Genome-wide Hoxa1 binding in differentiating ES cells maps to enhancer regions co-occupied by Hox cofactors; Hoxa1 targets multiple components of major signaling pathways (Wnt, TGF-β, Hedgehog, Hippo) and genes involved in neural crest migration, inner ear development, and heart development; two enhancers in Dok5 and Wls1 were validated for neural expression in mouse and zebrafish.\",\n      \"method\": \"ChIP-seq, differential gene expression analysis in Hoxa1 gain- and loss-of-function mouse and zebrafish, transgenic reporter assays\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — genome-wide binding data cross-validated with multiple species and in vivo enhancer reporter assays\",\n      \"pmids\": [\"28982536\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"KDM3B binds retinoic acid response elements (but not the promoter) of HOXA1 and demethylates H3K9 at those sites to transcriptionally activate HOXA1; KDM3B knockdown increases H3K9me1 but decreases H3K9me2 at the RARE region of HOXA1.\",\n      \"method\": \"KDM3B overexpression and knockdown, ChIP for KDM3B binding and H3K9 methylation marks, microarray profiling\",\n      \"journal\": \"Leukemia & lymphoma\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP-based mechanistic study showing site-specific histone demethylation, single lab\",\n      \"pmids\": [\"28540746\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"The lncRNA HOTAIRM1 activates HOXA1 transcription in GBM by sequestering histone methyltransferases G9a (H3K9me2) and EZH2 (H3K27me3) and DNA methyltransferases (DNMT1, DNMT3b) away from the HOXA1 gene TSS, causing histone and DNA demethylation at that locus.\",\n      \"method\": \"ChIP assay for histone marks, RNA-ChIP for HOTAIRM1-protein interactions, bisulfite sequencing PCR for DNA methylation, HOTAIRM1 knockdown\",\n      \"journal\": \"Journal of experimental & clinical cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple epigenetic readouts with RNA-ChIP for direct protein recruitment, single lab\",\n      \"pmids\": [\"30376874\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"The lncRNA HOTAIRM1 prevents PRC2 complex (EZH2) from binding the HOXA1 promoter and depositing H3K27me3, thereby maintaining HOXA1 expression in tamoxifen-resistant breast cancer cells; HOTAIRM1 directly interacts with EZH2.\",\n      \"method\": \"RNA immunoprecipitation (RIP) for HOTAIRM1-EZH2 interaction, ChIP for H3K27me3 at HOXA1 promoter, HOTAIRM1 knockdown\",\n      \"journal\": \"Journal of Cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — RIP and ChIP with functional knockdown, single lab\",\n      \"pmids\": [\"32284737\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"LncRNA HotairM1 recruits EZH2 and SUZ12 to the HOXA1 promoter, inducing H3K27 trimethylation and epigenetic silencing of HOXA1; silencing of HOXA1 subsequently induces H3K27 acetylation at the Nanog enhancer, upregulating Nanog expression and promoting cancer stem cell self-renewal in a reciprocal HOXA1-Nanog loop.\",\n      \"method\": \"ChIP for H3K27me3 and H3K27ac, EZH2/SUZ12 recruitment assay, HOXA1 knockdown, Nanog expression analysis\",\n      \"journal\": \"Molecular therapy. Nucleic acids\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP-based mechanistic study with identified chromatin-modifying complex and downstream epigenetic consequence, single lab\",\n      \"pmids\": [\"33230449\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"Hoxa1 homeodomain protein binds to a site approximately 60 bp upstream of the L1 neural cell adhesion molecule transcription start site, as demonstrated by in vitro DNA binding assays; this site is also recognized by Pax-6.\",\n      \"method\": \"In vitro DNA binding (gel shift/footprinting)\",\n      \"journal\": \"DNA and cell biology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single in vitro binding assay without functional follow-up for HOXA1 specifically\",\n      \"pmids\": [\"7917011\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"HOXA1 transcriptionally activates NF-κB RelA (p65) and KLF4 in vascular smooth muscle cells, promoting VSMC-to-macrophage-like phenotypic transformation; HOXA1 knockdown in ApoE−/− mice reduces atherosclerotic plaque formation and VSMC transdifferentiation.\",\n      \"method\": \"AAV1-shHOXA1 knockdown in ApoE−/− mice, in vitro VSMC model, Western blot, ChIP (implied by transcriptional activation claim)\",\n      \"journal\": \"Molecular medicine (Cambridge, Mass.)\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — mechanistic claim of transcriptional activation of RelA and KLF4 not fully supported by direct ChIP evidence in abstract; single lab\",\n      \"pmids\": [\"37528397\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"HOXA1 is a homeodomain transcription factor that functions as a master regulator of early hindbrain patterning (rhombomere identity specification), acting upstream of Hoxb1, EphA2, and neural crest specification genes; it is directly activated by retinoic acid through a 3' RARE-containing enhancer (modulated by RAR/RXR, SUZ12/PRC2, and lncRNAs such as linc-HOXA1 and HOTAIRM1), cooperates with PBX cofactors through its YPWM motif to bind composite Hox-Pbx DNA sites, activates NF-κB via non-transcriptional interaction with RBCK1/HOIL-1 and TRAF2, promotes cell survival through Bcl-2 and MAP kinase pathway upregulation in mammary epithelial cells, and is epigenetically regulated by histone demethylases KDM3A and KDM3B acting on H3K9 marks at its promoter/RARE regions.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"HOXA1 is a homeodomain transcription factor that serves as a master regulator of early hindbrain patterning, neural crest specification, and cardiac outflow tract development, acting as a primary transducer of retinoic acid signaling during embryogenesis. HOXA1 cooperates with PBX cofactors through its YPWM motif to bind composite Hox-Pbx DNA sites, directly activating targets including EphA2 and the Hoxb1 autoregulatory enhancer, and synergizes with HOXB1 to specify rhombomere 4/5 identity and generate cranial neural crest cells [PMID:1680563, PMID:9733765, PMID:9463359, PMID:11532923]. Its transcription is induced by retinoic acid through a 3′ RARE-containing enhancer and is epigenetically modulated by Polycomb (SUZ12/EZH2-mediated H3K27me3), H3K9 demethylases KDM3A and KDM3B, and lncRNAs linc-HOXA1 and HOTAIRM1 that regulate chromatin modifier access at the HOXA1 locus [PMID:1360810, PMID:17663992, PMID:23723417, PMID:25148682, PMID:30376874]. Beyond its canonical transcriptional roles, HOXA1 activates NF-κB signaling through a non-transcriptional mechanism involving physical interaction with RBCK1/HOIL-1 and TRAF2, and promotes oncogenic transformation of mammary epithelial cells by upregulating Bcl-2 and the p44/42 MAPK pathway [PMID:27382069, PMID:12482855, PMID:17213808].\",\n  \"teleology\": [\n    {\n      \"year\": 1991,\n      \"claim\": \"Establishing that Hoxa1 is essential for hindbrain segmentation resolved the question of whether individual Hox genes have non-redundant roles in anteroposterior patterning, revealing that Hoxa1 loss causes rhombomere 4–7 defects, cranial nerve agenesis, and inner ear malformations.\",\n      \"evidence\": \"Homologous recombination gene targeting producing Hoxa1 null mice in two independent labs\",\n      \"pmids\": [\"1680563\", \"1346922\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transcriptional targets of Hoxa1 in the hindbrain were unknown\", \"Whether Hoxa1 acts cell-autonomously was not established\", \"Cofactor requirements for Hoxa1 DNA binding were undefined\"]\n    },\n    {\n      \"year\": 1992,\n      \"claim\": \"Identifying a 3′ retinoic acid response element–containing enhancer established how RA directly activates Hoxa1 transcription, placing Hoxa1 as a primary RA-responsive gene in the Hox cascade.\",\n      \"evidence\": \"DNase I hypersensitivity mapping, lacZ reporter transgenic mice, RARE point mutations in F9 cells and in vivo\",\n      \"pmids\": [\"1360810\", \"7743939\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The identity of trans-acting factors beyond RAR/RXR at the enhancer was unknown\", \"Epigenetic regulation of the RARE locus had not been explored\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Demonstrating that the YPWM motif mediates cooperative DNA binding with PBX cofactors, and that HOXA1/PBX1/HOXB1 activate EphA2 and the Hoxb1 autoregulatory enhancer, defined the molecular logic by which Hoxa1 engages its transcriptional targets in hindbrain patterning.\",\n      \"evidence\": \"EMSA with YPWM mutagenesis, co-transfection reporter assays, transgenic embryo analysis, Hoxa1/Hoxb1 double-mutant mice\",\n      \"pmids\": [\"9582372\", \"9733765\", \"11278854\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genome-wide binding sites for HOXA1 were unknown\", \"Whether homeodomain residue differences between paralogs affect target selection in vivo was untested\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Compound Hoxa1/Hoxb1 double-mutant analyses revealed overlapping paralog functions in rhombomere 4/5 identity, second arch formation, and ear development that are cryptic in single mutants, establishing the genetic redundancy framework for Hox1 paralogs.\",\n      \"evidence\": \"Double knockout mice with neurofilament staining, retrograde labeling, molecular marker analysis\",\n      \"pmids\": [\"9463359\", \"9463349\", \"10529420\", \"10662633\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether functional redundancy reflects protein equivalence or regulatory overlap was unresolved\", \"Cell-autonomous versus non-cell-autonomous contributions were not distinguished\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Cell-autonomous requirement for Hoxa1/Hoxb1 in neural crest generation from r4 was established through grafting experiments, showing that Hoxa1 acts within neuroepithelium to specify neural crest competence rather than through secondary signaling.\",\n      \"evidence\": \"Ectoderm-specific double-mutant mice, grafting experiments in cultured embryos, lineage analysis\",\n      \"pmids\": [\"11532923\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct neural crest gene targets of Hoxa1 were not identified\", \"How Hoxa1 interfaces with neural crest induction pathways (Foxd3, Sox9) was mechanistically unclear\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Protein-swap knock-in experiments showed that HOXA1 and HOXB1 coding sequences are functionally interchangeable, demonstrating that paralog subfunctionalization is driven by regulatory element divergence rather than protein sequence differences.\",\n      \"evidence\": \"Knock-in mice with swapped coding regions, insertion of Hoxb1 autoregulatory enhancer into Hoxa1 locus\",\n      \"pmids\": [\"16890163\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether this interchangeability extends beyond hindbrain patterning to other tissues was not tested\", \"Post-translational modifications distinguishing paralogs were not addressed\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Discovery that forced HOXA1 expression transforms mammary epithelial cells via Bcl-2 upregulation and survival signaling expanded HOXA1 function beyond developmental patterning into oncogenic contexts.\",\n      \"evidence\": \"Forced expression in mammary cells, soft agar assays, tumor formation, Bcl-2 reporter assays\",\n      \"pmids\": [\"12482855\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether Bcl-2 is a direct transcriptional target (Hoxa1 binding at Bcl-2 regulatory regions) was not confirmed by ChIP\", \"Relevance to endogenous breast cancer was correlative\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Placing HOXA1 upstream of the p44/42 MAPK pathway through transcriptional activation of GRB2 and MEK1 defined the signaling axis through which HOXA1 promotes proliferation and transformation, with MEK inhibition blocking HOXA1 oncogenic activity.\",\n      \"evidence\": \"Microarray profiling, HOXA1 forced expression/depletion, MEK1 inhibitor epistasis, Western blot\",\n      \"pmids\": [\"17213808\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct binding of HOXA1 to GRB2/MEK1 regulatory regions was not shown\", \"In vivo relevance of the MAPK axis in HOXA1-driven tumors was not tested\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Revealing that SUZ12/PRC2 occupies the Hoxa1 RARE before RA treatment and is displaced upon RA exposure established the Polycomb-to-activation chromatin switch governing Hoxa1 induction, linking epigenetic silencing to the RA signaling response.\",\n      \"evidence\": \"ChIP for SUZ12, H3K27me3, H3ac, H3K4me2, and RNA Pol II in F9 embryonal carcinoma cells ± RA\",\n      \"pmids\": [\"17663992\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"The mechanism of PRC2 displacement was unknown\", \"Whether additional chromatin remodelers participate was not tested\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Lineage tracing with Hoxa1-IRES-Cre revealed that Hoxa1-expressing cells contribute directly to the otic epithelium, cardiac atria, outflow tract, and rhombomere 3, expanding the known developmental domains of Hoxa1 beyond the hindbrain.\",\n      \"evidence\": \"Cre-mediated lineage tracing in mouse embryos\",\n      \"pmids\": [\"20171203\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional requirement for Hoxa1 in cardiac and otic lineages was not established in this study\", \"Whether contributions to r3 reflect early transient expression was unclear\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Characterization of cardiovascular defects in Hoxa1 nulls (interrupted aortic arch, Tetralogy of Fallot) and identification of downstream targets (Zic1, Foxd3, Hnf1b, Pax8) by microarray placed Hoxa1 as a regulator of cardiac neural crest specification and defined its developmental gene network.\",\n      \"evidence\": \"Hoxa1 null cardiac phenotyping, microarray on microdissected embryonic tissue, compound mutant analysis with Hoxb1\",\n      \"pmids\": [\"21940751\", \"21784065\", \"26284287\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct binding of Hoxa1 to these downstream target promoters/enhancers was not shown\", \"Functional rescue experiments for individual targets were not performed\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Discovery that lncRNA linc-HOXA1 represses Hoxa1 in cis by recruiting PURB established a novel regulatory layer operating at the single-chromosome level, with RA overriding this repression during differentiation.\",\n      \"evidence\": \"Single-cell transcript counting, RNA FISH, allele-specific siRNA knockdown, PURB identification\",\n      \"pmids\": [\"23723417\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The mechanism by which PURB mediates transcriptional repression was undefined\", \"Whether linc-HOXA1 regulation operates in vivo during embryogenesis was not shown\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identification of ACK1-mediated phosphorylation of KDM3A (Y1114) as an activating signal for H3K9 demethylation at the HOXA1 promoter linked receptor tyrosine kinase signaling to HOXA1 epigenetic de-repression, connecting growth factor signaling with HOXA1 transcriptional control.\",\n      \"evidence\": \"In vitro kinase assay, phospho-site mutagenesis, ChIP for H3K9me2, pharmacological inhibitors\",\n      \"pmids\": [\"25148682\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether this ACK1-KDM3A-HOXA1 axis operates during normal development was not tested\", \"Additional substrates of ACK1 at the HOXA1 locus were not explored\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Demonstrating that HOXA1 activates NF-κB signaling non-transcriptionally through physical interaction with RBCK1/HOIL-1 and TRAF2 via its His-repeat and homeodomain revealed an unexpected cytoplasmic signaling function for a homeodomain transcription factor, required for its oncogenic activity.\",\n      \"evidence\": \"Yeast two-hybrid, co-immunoprecipitation, NF-κB reporter assays, domain deletion/mutagenesis, epistasis experiments\",\n      \"pmids\": [\"27382069\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether HOXA1-RBCK1/TRAF2 complexes form in physiological developmental contexts was untested\", \"The stoichiometry and dynamics of HOXA1 partitioning between nuclear and cytoplasmic functions were unknown\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Genome-wide ChIP-seq in differentiating ES cells mapped Hoxa1 occupancy to enhancers co-bound by Nanog and Hox cofactors, establishing direct cross-regulatory repression between Hoxa1 and the pluripotency network and defining HOXA1's genome-wide target repertoire across Wnt, TGF-β, Hedgehog, and Hippo pathway genes.\",\n      \"evidence\": \"ChIP-seq in RA-treated ES cells, reciprocal binding analysis, cross-species validation in mouse and zebrafish transgenic reporters\",\n      \"pmids\": [\"28584089\", \"28982536\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional validation of individual enhancer targets beyond Dok5 and Wls1 was limited\", \"Time-resolved binding dynamics during the RA response were not captured\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Studies in cancer cells showed that lncRNA HOTAIRM1 modulates HOXA1 expression bidirectionally — activating it in glioblastoma by sequestering G9a, EZH2, and DNMTs away from the TSS, and in other contexts recruiting EZH2/SUZ12 to silence it — revealing context-dependent epigenetic regulation of HOXA1 by the same lncRNA.\",\n      \"evidence\": \"RNA-ChIP, ChIP for H3K9me2/H3K27me3, bisulfite sequencing, RIP for HOTAIRM1-EZH2, HOTAIRM1 knockdown\",\n      \"pmids\": [\"30376874\", \"32284737\", \"33230449\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Contradictory roles of HOTAIRM1 (activating vs. silencing HOXA1) in different cell types were not reconciled mechanistically\", \"In vivo developmental relevance of HOTAIRM1-HOXA1 regulation was not established\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The structural basis for HOXA1's dual nuclear (transcription factor) and cytoplasmic (NF-κB activation) functions, and how cells partition HOXA1 between these roles during development versus oncogenesis, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No crystal or cryo-EM structure of HOXA1 alone or in complex with PBX/RBCK1\", \"Mechanism by which HOXA1 partitions between transcriptional and non-transcriptional functions is unknown\", \"Whether HOXA1's NF-κB activation has any developmental role has not been tested\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [3, 7, 12, 28, 29, 34]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [3, 5, 6, 13, 15, 28, 29]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [27]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [3, 7, 12, 22, 28, 29]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [22, 27]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [1, 2, 3, 5, 13, 15, 28, 29]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 4, 6, 8, 9, 18, 19, 26]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [15, 27, 29]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [16, 20, 24, 30, 31, 32, 33]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"PBX1\",\n      \"HOXB1\",\n      \"RBCK1\",\n      \"TRAF2\",\n      \"KDM3A\",\n      \"PURB\",\n      \"EZH2\",\n      \"SUZ12\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}